Organization · Other
L39 Capital
L39 Capital is an Australian investment manager based in Prahran, Victoria, focusing on micro and small-cap companies. The firm employs a patient capital approach and offers corporate advisory services alongside its investment activities.
Overview
What L39 Capital does
What L39 Capital is
L39 Capital is an Australian investment manager based in Prahran, Victoria, focusing on micro and small-cap companies. The firm employs a patient capital approach and offers corporate advisory services alongside its investment activities.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Other
- Founded
- Founded in 2016
- Approximate age
- About 10 years
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find L39 Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
L39 Capital as a funder
Investment thesis
L39 Capital seeks opportunities in overlooked micro and small-cap markets where lack of institutional attention creates information gaps. The firm looks for high-quality businesses run by competent management at prices that offer attractive returns.
Focus narrative
L39 Capital invests in micro and small-cap companies across various sectors, employing a structured investment process that includes top-down analysis, extensive due diligence, capital structuring, and active monitoring. The firm also provides corporate advisory services, leveraging its network to assist companies with refinancing and strategic support.
Value beyond capital
L39 Capital adds value to its portfolio companies through active participation, corporate advisory services, and leveraging its extensive network to assist with refinancing and strategic support. The firm emphasizes patient capital and alignment with investors to foster long-term growth.
Focus and fit
- Stages
- Friends and Family · Angel · Accelerator · Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity · Pre-IPO · Ipo · Secondary · Bridge · Recap
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 10
Portfolio context
Notable portfolio companies include: Aeeris Ltd (ASX: AER): Specializes in technology-driven alerting and information services. Papyrus Australia (ASX: PPY): Converts banana plantation waste into eco-friendly packaging products. Opyl Ltd (ASX: OPL): A digital health company using AI to improve clinical trials. Aegros: Develops high-purity plasma proteins. EasyPark Australia: A parking app simplifying urban parking. Eden Exchange: A platform for business buying and selling. Imunexus Therapeutics: Focuses on therapeutics using monoclonal antibodies. mDetect: Utilizes muons for structural intelligence. me&u: A mobile ordering platform for restaurants. Cannenta: Develops advanced wound care products.
Common questions
What to know about L39 Capital
Upseed classifies L39 Capital under the Other organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.